These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 27999191)
1. NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway. Gu Y; Yu H; Hao C; Martin TA; Hargest R; He J; Cheng S; Jiang WG Oncotarget; 2017 Jan; 8(5):7753-7765. PubMed ID: 27999191 [TBL] [Abstract][Full Text] [Related]
2. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer. Du G; Gu Y; Hao C; Yuan Z; He J; Jiang WG; Cheng S Oncotarget; 2016 May; 7(20):29440-53. PubMed ID: 27097111 [TBL] [Abstract][Full Text] [Related]
4. β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy. Saponaro C; Sergio S; Coluccia A; De Luca M; La Regina G; Mologni L; Famiglini V; Naccarato V; Bonetti D; Gautier C; Gianni S; Vergara D; Salzet M; Fournier I; Bucci C; Silvestri R; Passerini CG; Maffia M; Coluccia AML Oncogene; 2018 Jun; 37(24):3301-3316. PubMed ID: 29551770 [TBL] [Abstract][Full Text] [Related]
5. NHERF1/EBP50 is a new marker in colorectal cancer. Hayashi Y; Molina JR; Hamilton SR; Georgescu MM Neoplasia; 2010 Dec; 12(12):1013-22. PubMed ID: 21170265 [TBL] [Abstract][Full Text] [Related]
6. β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients. Schirosi L; Mazzotta A; Opinto G; Pinto R; Graziano G; Tommasi S; Fucci L; Simone G; Mangia A Oncotarget; 2016 Oct; 7(42):67841-67850. PubMed ID: 27765918 [TBL] [Abstract][Full Text] [Related]
7. A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression. Yang X; Du G; Yu Z; Si Y; Martin TA; He J; Cheng S; Jiang WG Anticancer Res; 2017 Jan; 37(1):67-73. PubMed ID: 28011475 [TBL] [Abstract][Full Text] [Related]
8. NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma. Saponaro C; Vagheggini A; Scarpi E; Centonze M; Catacchio I; Popescu O; Pastena MI; Giotta F; Silvestris N; Mangia A J Exp Clin Cancer Res; 2018 May; 37(1):96. PubMed ID: 29716631 [TBL] [Abstract][Full Text] [Related]
9. Dynamic relocalization of NHERF1 mediates chemotactic migration of ovarian cancer cells toward lysophosphatidic acid stimulation. Oh YS; Heo K; Kim EK; Jang JH; Bae SS; Park JB; Kim YH; Song M; Kim SR; Ryu SH; Kim IH; Suh PG Exp Mol Med; 2017 Jul; 49(7):e351. PubMed ID: 28684865 [TBL] [Abstract][Full Text] [Related]
10. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer. Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983 [TBL] [Abstract][Full Text] [Related]
12. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells. Pan Y; Weinman EJ; Dai JL Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691 [TBL] [Abstract][Full Text] [Related]
13. A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling. DU G; Hao C; Gu Y; Wang Z; Jiang WG; He J; Cheng S Anticancer Res; 2016 Mar; 36(3):1165-73. PubMed ID: 26977012 [TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of NHERF1 S279 and S301 differentially regulates breast cancer cell phenotype and metastatic organotropism. Greco MR; Bon E; Rubino R; Guerra L; Bernabe-Garcia M; Cannone S; Cayuela ML; Ciaccia L; Marionneau-Lambot S; Oullier T; Fromont G; Guibon R; Roger S; Reshkin SJ; Cardone RA Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):26-37. PubMed ID: 30326259 [TBL] [Abstract][Full Text] [Related]
15. Roles of NHERF1/EBP50 in cancer. Georgescu MM; Morales FC; Molina JR; Hayashi Y Curr Mol Med; 2008 Sep; 8(6):459-68. PubMed ID: 18781953 [TBL] [Abstract][Full Text] [Related]
16. The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer. Saponaro C; Malfettone A; Dell'Endice TS; Brunetti AE; Achimas-Cadariu P; Paradiso A; Mangia A Cancer Biomark; 2014; 14(2-3):177-84. PubMed ID: 24878819 [TBL] [Abstract][Full Text] [Related]
17. Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance. Vaquero J; Nguyen Ho-Bouldoires TH; Clapéron A; Fouassier L Oncogene; 2017 Jun; 36(22):3067-3079. PubMed ID: 28068322 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype. Malfettone A; Silvestris N; Paradiso A; Mattioli E; Simone G; Mangia A Exp Mol Pathol; 2012 Jun; 92(3):296-303. PubMed ID: 22440733 [TBL] [Abstract][Full Text] [Related]
19. Wnt signaling pathway upregulates DNMT1 to trigger NHERF1 promoter hypermethylation in colon cancer. Guo Y; Wang M; Jia X; Zhu H; Zhi Y; Yuan L Oncol Rep; 2018 Aug; 40(2):1165-1173. PubMed ID: 29901158 [TBL] [Abstract][Full Text] [Related]
20. Involvement of nuclear NHERF1 in colorectal cancer progression. Mangia A; Saponaro C; Malfettone A; Bisceglie D; Bellizzi A; Asselti M; Popescu O; Reshkin SJ; Paradiso A; Simone G Oncol Rep; 2012 Sep; 28(3):889-94. PubMed ID: 22766563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]